The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden

BACKGROUND: Warfarin is used for the prevention of stroke in chronic atrial fibrillation. The product has a narrow therapeutic index and to obtain treatment success, patients must be maintained within a given therapeutic range (International Normalised Ratio;INR). To ensure a wise allocation of heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Björholt, Ingela, Andersson, Stina, Nilsson, Gunnar H, Krakau, Ingvar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820599/
https://www.ncbi.nlm.nih.gov/pubmed/17324260
http://dx.doi.org/10.1186/1471-2296-8-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820599/
https://www.ncbi.nlm.nih.gov/pubmed/17324260
http://dx.doi.org/10.1186/1471-2296-8-6

Ejemplares similares